Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.35p
   
  • Change Today:
      0.050p
  • 52 Week High: 14.13
  • 52 Week Low: 3.30
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 164,059
  • Market Cap: £4.43m
  • RiskGrade: 435

Balance Sheet

  £ (Millions) £ (Millions)
Balance Sheet 31-Dec-10 31-Dec-09
Non-Current Assets    
Property, Plant & Equipment n/a 0.01
Intangible Assets 1.57 1.47
Investment Properties n/a n/a
Investments n/a n/a
Other Financial Assets n/a n/a
Other Non-Current Assets n/a n/a
  1.58 1.47
Current Assets    
Inventories 0.01 0.02
Trade & Other Receivables 0.81 0.16
Current Investments - Listed n/a n/a
Current Investments - Deposits n/a n/a
Current Investments - Unlisted n/a n/a
Cash at Bank & in Hand 0.11 0.02
Cash on Short Term Deposit n/a n/a
Other Current Assets n/a n/a
  0.92 0.19
     
Other Assets n/a n/a
Total Assets 2.50 1.67
     
Current Liabilities    
Trade & Other Payables 0.50 0.71
Borrowings n/a 0.05
Finance Lease Obligations n/a n/a
Other Current Liabilities n/a n/a
  0.50 0.76
     
Net Current Assets en/a en/a
     
Non-Current Liabilities    
Borrowings n/a n/a
Finance Lease Obligations n/a n/a
Other Non-Current Liabilities n/a n/a
Provisions - Deferred Tax n/a n/a
Provisions - Other n/a n/a
  n/a n/a
     
Other Liabilities n/a n/a
Total Liabilities 0.50 0.76
     
Net Assets 2.00 0.91
     
Share Capital 4.83 4.45
Share Premium Account 0.64 0.07
Other Reserves 1.26 1.25
Retained Earnings (4.73) (4.86)
  2.00 0.91
     
Minority Interests/Other Equity n/a n/a
Total Equity 2.00 0.91
  £ (Millions) £ (Millions)
Notes to Balance Sheet 31-Dec-10 31-Dec-09
Shareholders Funds - Equity en/a en/a
Shareholders Funds - Non Equity en/a en/a
  en/a en/a
     
Borrowing Analysis    
Borrowings Under 1 year n/a n/a
Due 1 - 2 years n/a n/a
Due 2 - 5 years n/a n/a
Due After 5 years n/a n/a
Due 1 - 5 years Unanalysed n/a n/a
Due After 1 year Unanalysed n/a n/a
Less: Borrowings in Other Creditors n/a n/a
Total Borrowings n/a 0.05
     
Property, Plant & Equipment Analysis    
Property    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchanges & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Depreciation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Net Book Value n/a n/a
     
Other Fixed Assets    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Other Fixed Assets Deprecation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
At End of Year n/a n/a
     
Other Fixed Assets Net Book Value n/a n/a
     
Total Property, Plant & Equipment Net Book Value n/a n/a

Key

* GAAP

a. Total fixed assets

b. Debtors due within and after one year

c. Includes trade and other payables

d. Includes non-current assets

e. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page